UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic potential of cannabis in pain medicine

British Journal of Anaesthesia, 2008-07, Vol.101 (1), p.59-68

2008

Volltextzugriff (PDF)

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Journal of neurology, neurosurgery and psychiatry, 2005-12, Vol.76 (12), p.1664-1669

2005

Volltextzugriff (PDF)

Can the ABILHAND handle manual ability in MS?

Multiple sclerosis, 2013-05, Vol.19 (6), p.806-815

2013

Volltextzugriff (PDF)

Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis

Multiple sclerosis, 2011-02, Vol.17 (2), p.214-222

2011

Volltextzugriff (PDF)

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

Neurology, 2004-10, Vol.63 (7), p.1245-1250

2004

Volltextzugriff (PDF)

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)

Brain (London, England : 1878), 2006-01, Vol.129 (1), p.224-234

2006

Volltextzugriff (PDF)

Designing clinical trials in older people

Maturitas, 2011-04, Vol.68 (4), p.337-341

2011

Volltextzugriff (PDF)

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

Journal of neurology, 2008-02, Vol.255 (2), p.231-238

2008

Volltextzugriff (PDF)

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

Multiple sclerosis, 2012-06, Vol.18 (6), p.853-861

2012

Volltextzugriff (PDF)

Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease

Neurochemistry international, 2011-08, Vol.59 (1), p.73-80

2011

Volltextzugriff (PDF)

Central nervous system sarcoidosis—diagnosis and management

QJM : An International Journal of Medicine, 1999-02, Vol.92 (2), p.103-117

1999

Volltextzugriff (PDF)

Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

Neuropathology and applied neurobiology, 2012-10, Vol.38 (6), p.535-547

2012

Volltextzugriff (PDF)

The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria

Journal of neurology, neurosurgery and psychiatry, 2004-01, Vol.75 (1), p.56-60

2004

Volltextzugriff (PDF)

Melanoma following treatment with alemtuzumab for multiple sclerosis

European journal of neurology, 2009-04, Vol.16 (4), p.e70-e71

2009

Volltextzugriff (PDF)

PONM01 Measurement of global strength: stable concept, fluid ruler

Journal of neurology, neurosurgery and psychiatry, 2010-11, Vol.81 (11), p.e60-e61

2010

Volltextzugriff (PDF)

PONM02 Grading strength in manual muscle testing: bespoke works better

Journal of neurology, neurosurgery and psychiatry, 2010-11, Vol.81 (11), p.e61-e61

2010

Volltextzugriff (PDF)

The 'harlequin' sign in association with multiple sclerosis

Journal of neurology, 2004-09, Vol.251 (9), p.1145

2004

Volltextzugriff (PDF)

Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing

Brain (London, England : 1878), 1992-12, Vol.115 ( Pt 6) (6), p.1611-1631

1992

Volltextzugriff (PDF)

MOLECULAR GENETIC STUDIES OF NEURODEGENERATIVE DISEASE

Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.e2-e2

2013

Volltextzugriff (PDF)

Cerebral vasculitis—recognition, diagnosis and management

QJM : An International Journal of Medicine, 1997-01, Vol.90 (1), p.61-73

1997

Volltextzugriff (PDF)

Δ 9 ‐tetrahydrocannabinol (Δ 9 ‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

Neuropathology and applied neurobiology, 2012-10, Vol.38 (6), p.535-547

2012

Volltextzugriff (PDF)

Muscle cramps and weakness secondary to graft versus host disease fasciitis

European journal of neurology, 2005-04, Vol.12 (4), p.320-322

2005

Volltextzugriff (PDF)

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Journal of neurology, neurosurgery and psychiatry, 2012-11, Vol.83 (11), p.1125-1132

2012

Volltextzugriff (PDF)

POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease

Journal of neurology, neurosurgery and psychiatry, 2010-11, Vol.81 (11), p.e60-e60

2010

Volltextzugriff (PDF)

FAAH INHIBITION IS PROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE

Journal of neurology, neurosurgery and psychiatry, 2012-11, Vol.83 (Suppl 2), p.A15-A15

2012

Volltextzugriff (PDF)

1 – 25 von 206

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(205)
Schwedisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic potential of cannabis in pain medicine

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Can the ABILHAND handle manual ability in MS?

Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)

Designing clinical trials in older people

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

Changes in iron-regulatory gene expression occur in human cell culture models of Parkinson’s disease

Central nervous system sarcoidosis—diagnosis and management

Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria

Melanoma following treatment with alemtuzumab for multiple sclerosis

PONM01 Measurement of global strength: stable concept, fluid ruler

PONM02 Grading strength in manual muscle testing: bespoke works better

The 'harlequin' sign in association with multiple sclerosis

Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing

MOLECULAR GENETIC STUDIES OF NEURODEGENERATIVE DISEASE

Cerebral vasculitis—recognition, diagnosis and management

Δ 9 ‐tetrahydrocannabinol (Δ 9 ‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

Muscle cramps and weakness secondary to graft versus host disease fasciitis

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease

FAAH INHIBITION IS PROTECTIVE IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE

Suchergebnisse filtern